XML 128 R60.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2014
Valuation and Qualifying Accounts Disclosure [Line Items]  
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
SCHEDULE I – CONSOLIDATED ALLOWANCE FOR DOUBTFUL ACCOUNTS RECEIVABLE

(In thousands)
2014
 
2013
 
2012
Balance at beginning of period
$
19,602

 
$
19,028

 
$
6,405

Additions:
 
 
 
 
 
Charged to costs and expenses
7,217

 
4,966

 
14,041

 
7,217

 
4,966

 
14,041

Deductions:
 
 
 
 
 
Write-offs and recoveries
11,762

 
4,580

 
1,736

Foreign exchange and other, net
619

 
(188
)
 
(318
)
 
12,381

 
4,392

 
1,418

Balance at end of period
$
14,438

 
$
19,602

 
$
19,028


SCHEDULE I – CONSOLIDATED CHANGE IN TAX VALUATION ALLOWANCE

(In thousands)
2014
 
2013
 
2012
Balance at beginning of period
$
298,705

 
$
246,425

 
$
104,276

Additions:
 
 
 
 
 
U.S. net deferred tax assets
48,571

 
47,326

 
41,052

Valuation allowance

 

 
88,554

Foreign net deferred tax assets
29,730

 
16,956

 
14,937

Prior year U.S. NOL adjustments

 

 
387

 
78,301

 
64,282

 
144,930

Deductions:
 
 
 
 
 
U.S. net deferred tax assets

 

 

Valuation allowance release

 
1,258

 

Foreign net deferred tax assets

 

 

Prior year foreign NOL adjustments
10,657

 
5,438

 
2,781

Prior year U.S. NOL adjustments
62

 
5,306

 

 
10,719

 
12,002

 
2,781

Balance at end of period
$
366,287

 
$
298,705

 
$
246,425

Schedule of Quarterly Financial Information
2014
(In thousands, except per share amounts)
March 31
 
June 30
 
Sept. 30
 
Dec. 31
Net sales
$
761,990

 
$
825,847

 
$
738,551

 
$
763,836

Cost of sales
685,252

 
716,307

 
663,536

 
670,022

Gross profit
76,738

 
109,540

 
75,015

 
93,814

Operating income (loss)
588

 
36,733

 
(1,438
)
 
(8,479
)
Net income (loss)
(24,603
)
 
17,836

 
(17,956
)
 
(37,813
)
 
 
 
 
 
 
 
 
Common stock market price:
 
 
 
 
 
 
 
High
$
12.45

 
$
12.64

 
$
14.35

 
$
14.48

Low
10.02

 
10.10

 
9.59

 
13.16


2013
(In thousands, except per share amounts)
March 31
 
June 30
 
Sept. 30
 
Dec. 31
Net sales
$
774,252

 
$
812,171

 
$
723,062

 
$
747,997

Cost of sales
679,151

 
693,346

 
645,170

 
690,761

Gross profit
95,101

 
118,825

 
77,892

 
57,236

Operating income (loss)
25,138

 
40,576

 
1,153

 
(17,022
)
Net income (loss)
2,377

 
31,100

 
(17,814
)
 
(31,478
)
 
 
 
 
 
 
 
 
Common stock market price:
 
 
 
 
 
 
 
High
$
8.25

 
$
11.05

 
$
13.57

 
$
12.90

Low
6.10

 
7.05

 
11.03

 
9.41